What is Alzheimer's disease?
Alzheimer’s disease is the most common cause of dementia, thought to account for over 50% of cases. Like most other types of dementia, Alzheimer’s disease is progressive, with symptoms worsening over time.
The brain changes typically found in Alzheimer's disease were first described by the German psychiatrist Alois Alzheimer in 1906.
Alzheimer’s disease used to be most frequently diagnosed when people already had dementia and were experiencing quite noticeable problems with memory loss, thinking ability and daily activities.
Nowadays, Alzheimer’s disease is considered a continuum ranging from a pre-clinical (at-risk for dementia) state, to a form of mild cognitive impairment with only minor problems with daily activities and on to mild, moderate and severe dementia with increasing loss of cognitive and everyday function.
The disease progression
Alzheimer’s disease begins many years before symptoms become apparent and develops gradually over time.
As people progress along the Alzheimer’s disease continuum, cognitive and functional impairments gradually become more severe, with an eventual loss of independence and hence, a need for support from other people. However, it is important to understand that progression along the Alzheimer’s disease continuum varies considerably from person to person and that each person’s experience of Alzheimer’s disease will be unique to them.
Moreover, in keeping with the United Nations Convention on the Rights of People with Disabilities, dementia is also considered a disability. Article 1 states:
"(p)ersons with disabilities include those who have long-term physical, mental, intellectual or sensory impairments which in interaction with various barriers may hinder their full and effective participation in society on an equal basis with others"
For this reason, it is important to consider the physiological/biomedical aspects of Alzheimer’s disease but also the interaction between people with cognitive impairment, other people, situations and societal structures as this, in addition, impacts on the wellbeing, opportunities and overall experience of having dementia.
Latest news
News
Ensuring the success of PREDICTOM through effective partnership management
Robin Verjans, Program Manager at Lygature, highlights the importance of effective project management in PREDICTOM which supports the day-to-day work of each partner and ultimately ensures the achievement of PREDICTOM's objectives.
News
''Our models will cover the entire patient's journey: from a patient at home, up to a visit to a healthcare specialist in a memory clinic.''
Holger Fröhlich - Head of AI & Data Science at Fraunhofer SCAI, explains his work on PREDICTOM and sheds light on the data models used in the project as well as the ambitions for wider use of PREDICTOM's data platform.
News
In search for indicators of Alzheimer's disease to detect and track cognitive decline
Spiros Nikolopoulos, Principal Researcher at Centre for Research and Technology Hellas (CERTH), elaborates on his work within PREDICTOM and the importance of finding biomarkers for early detection of Alzheimer's disease. “My motivation has been to help doctors perform their miracles in fighting cognitive decline.”